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SHORT COMMUNICATION
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Polypeptide growth factors play an important role in the in
'itr)o growth of many human cancer cells (Rozengurt, 1983;
Goustin et al., 1986). Recently, factors have been identified
which are unique in their ability to induce a transformed
phenotype on normal cells in culture (DeLarco & Todaro,
1978). Exposure of cells to these factors causes loss of
density-dependent growth inhibition in monolayer cultures
and promotes anchorage-independent growth in semi-solid
media. After removal of these factors the cells convert back
to their normal appearance. Some of these factors have been
characterized in detail and have been termed 't-Trans-
forming Growth Factors' (aTGFs) (Tam et al., 1984; Derynck
et al., 1984). xTGFs are polypeptides with a molecular
weight of -5.7 kD. They consist of 50 amino acids and
contain three disulfide bonds which are important for their
biologic function. oTGFs bind to the membrane receptor for
epidermal growth factor (EGF) and, like EGF, activate a
tyrosine kinase (Todaro et al., 1980; Pike et al., 1982;
Reynolds et al., 1981). Binding to the receptor for EGF and
kinase activation are thought to be necessary events for all
subsequent biologic actions of ocTGFs.
iTGFs are present in conditioned media and cell extracts
from a variety of transformed cells in culture (Marquardt &
Todaro, 1982; Salomon et al., 1984). It has been suggested
that aTGFs act back on tumour cells and stimulate cell
proliferation in a positive feed-back manner (autocrine
secretion) (Sporn & Todaro, 1980). This would render
growth of these cells independent from physiologic control
mechanisms. On the other hand, it would offer new
potentials for treatment with antagonists (Nestor et al., 1985)
or antibodies to oTGF or the oxTGF receptor.
The purpose of our present study was to determine
whether human colon cancer cell lines release xTGF-like
substances. This may point to a potential role of autocrine
self-stimulation in the growth of these cell lines and provide
an important lead for a strategy to control colorectal
carcinoma.
Human colon cancer cell lines (COLO 205, COLO 320,
DLD-1, HOT-3, HT-29, LoVo, OM-1, SW-620, WIDR)
were purchased from the American Type Culture Collection,
Rockville, MD. Cells were cultured in 150cm2 tissue culture
flasks (Corning) until subconfluent to confluent. The
medium was removed and the cells were washed twice with
phosphate-buffered saline/0.lI % bovine serum albumin (BSA,
Sigma, St. Louis, MO). Serum-free medium was then added
for conditioning. After incubation for 48-72h at 37 C, 5%
CO, the conditioned media (CM) were collected and
remaining cells and debris removed by centrifugation. CM
and an equal volume of unconditioned serum-free medium
were dialyzed against 1% acetic acid (MCB, Cincinnati, OH)
at 4 C. The dialysate was then lyophilized. Prior to testing,
the lyophilysate was reconstituted with 10mM acetic
acid/0.1% BSA and cleared by ultracentrifugation (80,000g,
45min). The supernatant was aliquoted and either used for
assays or stored at -20 C.
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Normal rat kidney (NRK) fibroblasts strain 49-F were
purchased from the American Type Culture Collection,
Rockville, MD, and cultured in Dulbecco's Minimal
Essential Medium (DMEM, GIBCO) in the presence of 5%
fetal calf serum (FCS, GIBCO). The cells were harvested
using 0.25% trypsin in 1 mm EDTA (GIBCO). The assay
was performed in 35 mm dishes (Corning). One ml of
DMEM/10% FCS containing 0.8% agarose (FMC,
Rockland, ME) was pipetted into each dish as a baselayer.
To each dish, a mixture of DMEM/10% FCS, 0.4%
agarose, 3,000 NRK 49-F cells and 0.3 ml of CM or
unconditioned medium was then added to make a final
volume of I ml as a toplayer. All determinations were done
in triplicate. Controls with 10mm acetic acid/0.10% BSA and
EGF (2 ngml - 1) were included for each experiment. The
plates were incubated at 37 C, 5% CO2 in a humidified
environment. Cell aggregates >70,um were defined as
colonies and were counted with an inverted microscope after
7-10 days. Epidermal growth factor was obtained from
Collaborative Research (Lexington, MA). '25I-EGF was
purchased from Biomedical Technologies Inc. (Cambridge,
MA) at specific activities between 150 and 250 m Ci mg- 1.
MCF-7 human breast cancer cells were a generous gift from
Dr C.K. Osborne. The cells were seeded in 6-well plates
(Corning) at 4.5 x I05 cells/well and cultured until nearly
confluent. The radioreceptor assay was performed as
described earlier (Osborne et al., 1982). All determinations
were done in triplicate. Data were expressed as mean and
standard deviation of triplicate determinations. The
Student's paired t-test was used for significance calculations.
Figure 1 summarizes the results of the NRK trans-
formation assay. The conditioned media of seven cell lines
(COLO 320, DLD-1, HOT-3, HT-29, LoVo, SW-620,
WIDR) showed a statistically significant stimulation of
anchorage-independent growth as compared to
unconditioned media or 10mM acetic acid/0.1% BSA. The
CM of OM-1 also led to a stimulation of colony formation
but the difference to the unconditioned medium was only of
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Figure I Ability of conditioned media from nine colon cancer
cell lines to induce colony formation in a NRK transformation
assay. A: 10mM acetic acid/0.1% BSA. U: unconditioned
medium. C: conditioned medium. * =significant difference
compared to unconditioned medium using Student's paired t-test.
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borderline significance (P =0.067). Only CM from COLO
205 was clearly devoid of any colony stimulating activity.
These data indicate that the majority of colon cancer cell
lines release an activity which stimulates anchorage-
independent growth of normal fibroblasts.
The results of the EGF binding studies are shown in
Figure 2. A significant competition with EGF for receptor
binding was observed with CM from 4 of the 9 cell lines
tested (COLO 320, DLD-1, OM-1, SW-620). CM from
WIDR, LoVo, and HT-29 cells also competed for EGF
receptor binding but differences between CM and
unconditioned media were not statistically significant
(WIDR: P=0.07, LoVo: P=0.13, HT-29: P=0.07). CM
from HOT-3 cells showed discordant effects in that
stimulation of NRK colony growth was not accompanied by
a decrease in 125I-EGF binding. Conditioned medium from
COLO 205 had no effect on EGF binding.
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Figure 2 Ability of conditioned media from nine colon cancer
cell lines to inhibit 1251-EGF binding in a radioreceptor assay. A:
10mM acetic acid/0.1% BSA. U: unconditioned medium. C:
conditioned medium. *=significant difference compared to
unconditioned medium using Student's paired t-test.
While NRK colonies stimulated by EGF or aTGF
typically are spheroid, a distinctly different morphology of
colonies from CM of two cell lines was observed. As shown
in Figure 3a and 3b, CM from HOT-3 and OM-1 stimulated
NRK cells to form bizarrely shaped colonies. Serial dilutions
of the CM showed a dose-response effect. Atypical colony
morphology may be an indication for the involvement of
other factors besides xTGF which determine growth and
structure of NRK colonies.
Our studies indicate that the majority of colon cancer cell
lines tested released a stimulatory factor which was xTGF-
like in its activity. Except for conditioned media from HOT-
3 and COLO 205, results from both the NRK trans-
formation assay and EGF binding studies were compatible
with the presence of x.TGF-like activity. When statistically,
analyzed, results were significant in both assays for COLO
320, DLD-1, and SW-620. Equivocal results were obtained
in the NRK assay for CM from OM-1 and in EGF binding
studies for CM from HT-29, LoVo, and WIDR. However,
each of these CM showed a trend towards a difference from
unconditioned media. These trends may indicate the presence
of xTGF-like activity in low concentrations since we
collected relatively small amounts of conditioned media. Our
results further indicate that COLO 205 cells do not release
otTGF-like activity. Conditioned medium from HOT-3 cells
appear to contain substances which may be of particular
interest for future research since they do not bind to EGF
receptors and stimulate formation of NRK colonies which
are atypically shaped.
The assays used in our studies test for different functional
properties of the xTGF molecule. However, they are not
specific for oTGF. NRK colony formation is dependent on
Figure 3 Induction of atypical colonies in the NRK trans-
formation assay by conditioned media from two colon cancer cell
lines. A: HOT-3; B: OM-1. Bar= 100,pm.
the interaction of at least three different growth factors:
PDGF, f1-TGF, and EGF/ocTGF (Assoian et al., 1984), and
hence other growth factors present in the conditioned
medium might have contributed to colony formation. It is
also possible that the absence of necessary growth factors
could have prevented colony formation in the presence of
oaTGF. Since we have performed the NRK assay in the
presence of 10% FCS and have included into each
experiment a set of plates with EGF (2 ngml- ') to
demonstrate that the NRK cells were able to form colonies,
we feel confident that no false negative results were
observed. In addition, EGF binding studies are not specific
for otTGF since obviously EGF will mimic the effects of
aTGF. The higher frequency of equivocal results with the
radioreceptor assay may point to a somewhat lower
sensitivity of this assay.
The results of the present study are in agreement with a
recent report by Coffey et al. (1986) on the presence of
transforming growth factors in three colon cancer cell lines
(SW-480, SW-620, WIDR) and provide independent evidence
for the release of cxTGF-like activity by SW-620 and WIDR
cells. SW-620 cells seem to release a high amount of xTGF-
like activity as measured by EGF receptor binding studies.
In addition, our studies indicate that DLD-1 cells probably
are as active as SW-620 cells in releasing EGF competing
activity. However, studies relating the activity of CM to the
number of tumour cells need to be performed to precisely
define the relative activity of different cell lines.
Autocrine mechanisms might be involved in the growth
regulation of human colon cancer cells.
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